Jared Gollob is Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR). They have made 7 open-market trades across 1 company since 2021, most recently 2026-03-04.
CIK 0001821198
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KYMR | 117,134 | $12.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KYMR | SELL | 2026-03-02 | 2026-03-04 | $87.24 | $917K | -6.9% | -0.3% | -16.5% |
| KYMR | SELL · 10b5-1 | 2025-12-08 | 2025-12-08 | $88.51 | $8.3M | -12.2% | -15.5% | -6.3% |
| KYMR | SELL · 10b5-1 | 2025-10-15 | 2025-10-15 | $61.42 | $7.3M | -2.8% | +3.8% | +18.4% |
| KYMR | SELL · 10b5-1 | 2025-10-13 | 2025-10-14 | $60.00 | $187K | +0.1% | +8.8% | +25.0% |
| KYMR | SELL | 2025-03-03 | 2025-03-03 | $30.40 | $317K | +15.1% | -9.3% | +48.4% |
| KYMR | SELL · 10b5-1 | 2024-07-15 | 2024-07-16 | $45.53 | $3.6M | -6.6% | -7.7% | -3.4% |
| KYMR | SELL | 2024-03-04 | 2024-03-04 | $41.69 | $224K | -5.6% | -11.3% | -24.6% |
| KYMR | SELL · 10b5-1 | 2024-02-27 | 2024-02-29 | $45.00 | $18K | -2.8% | -8.5% | -24.6% |
| KYMR | SELL · 10b5-1 | 2024-02-09 | 2024-02-09 | $35.50 | $3.3M | +9.4% | +14.3% | +4.3% |
| KYMR | SELL · 10b5-1 | 2023-03-02 | 2023-03-03 | $31.00 | $40K | -5.5% | -9.8% | -10.7% |
| KYMR | SELL | 2021-11-01 | 2021-11-02 | $62.19 | $5.9M | -2.9% | -16.4% | -35.1% |
| KYMR | SELL | 2021-03-11 | 2021-03-15 | $60.13 | $1.8M | -34.6% | -40.0% | -16.3% |
| KYMR | SELL | 2021-02-22 | 2021-02-24 | $50.68 | $3.8M | -4.2% | -26.4% | -15.4% |
| KYMR | SELL | 2021-02-17 | 2021-02-19 | $56.42 | $2.6M | -16.7% | -12.9% | -20.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.